Ausgabe 1/2003
Inhalt (19 Artikel)
Influence of diabetes mellitus on heart failure risk and outcome
Christophe Bauters, Nicolas Lamblin, Eugène P Mc Fadden, Eric Van Belle, Alain Millaire, Pascal de Groote
Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress.
Melvin R Hayden, Suresh C Tyagi
Monocyte matrix metalloproteinase production in Type 2 diabetes and controls – a cross sectional study
Mark D Baugh, Jelena Gavrilovic, Isabel R Davies, David A Hughes, Mike J Sampson
Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
Alexander Tenenbaum, Enrique Z Fisman, Michael Motro
Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerance.
Marek Straczkowski, Irina Kowalska, Agnieszka Nikolajuk, Stella Dzienis-Straczkowska, Malgorzata Szelachowska, Ida Kinalska
Decreased expression of β1- and β2-adrenoceptors in human diabetic atrial appendage
U Deniz Dinçer, Şahika Güner, Aydin Tay, Ebru Arioğlu, Atilay Taşdelen, Sait Aşlamaci, Keshore R Bidasee
Metabolic and haemodynamic effects of oral glucose loading in young healthy men carrying the 825T-allele of the G protein β3 subunit
Jens Nürnberger, Sandra Dammer, Thomas Philipp, Rene R Wenzel, Rafael F Schäfers
Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil
Ulrich Dietz, Hans-Peter Tries, Walter Merkle, Cornelia Jaursch-Hancke, Heinz Lambertz
Silent myocardial infarction in women with impaired glucose tolerance: The Northern Sweden MONICA study
Dan Lundblad, Mats Eliasson
Brachial-ankle pulse wave velocity and symptomatic cerebral infarction in patients with type 2 diabetes: a cross-sectional study
Osamu Ogawa, Tomio Onuma, Sayaka Kubo, Naomi Mitsuhashi, Chie Muramatsu, Ryuzo Kawamori
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof
Enrique Z Fisman, Michael Motro, Alexander Tenenbaum
Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease
Hillary A Tuttle, Grace Davis-Gorman, Steven Goldman, Jack G Copeland, Paul F McDonagh
Usefulness of electronic databases for the detection of unrecognized diabetic patients
Shlomo Vinker, Yaacov Fogelman, Asher Elhayany, Sasson Nakar, Ernesto Kahan
Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus
Alexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, Yehuda Adler, Michal Benderly, Michael Motro, Joseph Shemesh
The insertion/deletion variation in the α2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes
Amir Snapir, Mika Scheinin, Leif C Groop, Marju Orho-Melander
Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study
Giuseppe MC Rosano, Cristiana Vitale, Barbara Sposato, Giuseppe Mercuro, Massimo Fini
Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial
Klaus Empen, Robert JA Frost, H Christian Geiss, Carsten Otto, Klaus G Parhofer
Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model
Ariel Roguin, Samy Nitecki, Irit Rubinstein, Eviatar Nevo, Aaron Avivi, Nina S Levy, Zaid A Abassi, Edmond Sabo, Orit Lache, Meira Frank, Aaron Hoffman, Andrew P Levy
High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study
Mats CE Eliasson, Jan-Håkan Jansson, Bernt Lindahl, Birgitta Stegmayr